ArticleNeuro-oncology2017

ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models.

Jadith Ziegler et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.